Physician profile
Qaiser Shamshir Khan
NPI 1861806192
$2,176.23
in general payments reported to CMS, 2019-2025
7 companies · $234 in 2025
The $234 reported for 2025 was more than what a typical Addiction Psychiatry provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,153 · 2021: $18.88 · 2023: $771 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $667 · Food and Beverage: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $666.80 |
| Food and Beverage | $338.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $1,031.39 | 2019 | |
| Penumbra, INC. | $691.20 | 2023 | Penumbra Coil 400 |
| Abbott Laboratories | $225.70 | 2023-2025 | Perclose Proglide, Jeti Peripheral Catheter |
| Boston Scientific Corporation | $121.13 | 2019 | |
| Medtronic, INC. | $67.84 | 2025 | Symplicity G3 |
| Lilly USA, LLC | $20.09 | 2025 | Zepbound |
| E.R. Squibb & Sons, L.L.C. | $18.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Qaiser Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.